AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Cladribine in South Africa
2 products registered with SAHPRA — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| MAVENCLAD 10 mg | 53/32.16/0218 | Merck (Pty) Ltd | active | 11 Oct 2027 |
| LITAK 10 | 38/26/0057 | Key Oncologics (Pty) Ltd | active | 1 Jan 1900 |
Cladribine — SAHPRA Registration Details
SAHPRA (South Africa) has 2 registered products containing Cladribine, of which 2 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Cladribine registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.